About
0.13AUD-0.01 -3.70%
Closed • Updated at 18:24 GMT+00:00Market Cap$49.50M
Volume1.15M
Beta-0.82
RSI41.61
Amplia Therapeutics Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 19 2026
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
May 19 2026
Amplia Launches First Stage of Pivotal Narmafotinib Trial
May 9 2026
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
May 8 2026
Amplia and ANZGOG announce Ovarian Cancer Study
Apr 22 2026
Accent Trial Mature Data Presented at International Conference
Translate